Your browser doesn't support javascript.
loading
Streamlining breast cancer and colorectal cancer biosimilar regulations to improve treatment access in Latin America: an expert panel perspective.
Teran, Enrique; Gomez, Henry; Hannois, Damian; Lema, Mauricio; Mantilla, William; Rico-Restrepo, Mariana; McElwee, Elizabeth; Castro Sanchez, Noe; Valdivieso, Natalia; Espinoza, Manuel Antonio.
Affiliation
  • Teran E; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador. Electronic address: eteran@usfq.edu.ec.
  • Gomez H; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • Hannois D; Clínica Indisa, Santiago, Chile.
  • Lema M; Clinica de Oncologia Astorga, Medellin, Colombia.
  • Mantilla W; Fundación Cardioinfantil, Universidad del Rosario, Bogota, Colombia.
  • Rico-Restrepo M; Americas Health Foundation, Bogota, Colombia.
  • McElwee E; Americas Health Foundation, Washington, DC, USA.
  • Castro Sanchez N; Escuela de Ciencias Medicas, Universidad San Carlos de Guatemala, Ciudad de Guatemala, Guatemala.
  • Valdivieso N; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Espinoza MA; Facultad de Medicina, Catholic University of Chile, Santiago, Chile.
Lancet Oncol ; 23(7): e348-e358, 2022 07.
Article in En | MEDLINE | ID: mdl-35772466

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms / Biosimilar Pharmaceuticals Type of study: Guideline Limits: Female / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms / Biosimilar Pharmaceuticals Type of study: Guideline Limits: Female / Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United kingdom